Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease

Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorXeno Holdings (US), LLC dba ChoironeX

About this trial

The goal of this clinical trial is to learn if a GalKO Porcine Thymokidney can maintain renal function, without the need for dialysis, after transplantation into adult subjects with End Stage Renal Disease.

Eligibility criteria

Qualifiers

ESRD receiving hemodialysis or peritoneal dialysis for ≥6 months

Eligible for kidney transplantation per site criteria

<50% likelihood of receiving a standard deceased-donor kidney transplant within 12 months

Blood type and immunologic compatibility with study transplant confirmed by testing

Disqualifiers

Requirement for multi-organ transplantation

Living donor available who is ABO-incompatible

Kidney disease with high risk of post-transplant recurrence

Polycystic kidney disease without prior native nephrectomy

Trial design

Treatments tested in this trial

  • ChoironeX GalKO Porcine Thymokidney

Treatment groups

4 Participants
are divided into 1 treatment group